3D PREDICT
DEAD

Serial Number

90818228

Owner

KIYATEC Inc.

Attorney

Kathrynn M. Lyddane

Filing Date

Jul 8, 2021

Add to watchlist:

No watchlists yet
View on USPTO

3D PREDICT Trademark

Serial Number: 90818228

3D PREDICT is a trademark filed by KIYATEC Inc. on July 8, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

KIYATEC Inc. (11 trademarks)

900-B W Faris Road
Greenville, SC 29605

Entity Type: 03

Trademark Details

Filing Date

July 8, 2021

Registration Date

Not Registered

Goods & Services

Scientific instruments and apparatus for ex vivo three-dimensional cell culture, namely, bioreactor for cell culturing, for laboratory use; scientific instruments and apparatus for ex vivo microtumor modeling

Assay kits comprising clinical medical reagents for culturing cells for clinical medical use

Assays for clinical laboratory or research purposes, namely, for testing anti-cancer therapies, other than for medical or veterinary use; Assays for use in anti-cancer therapy research; Assays for testing cellular response to anti-cancer therapies, other than for medical or veterinary use; Assay kits comprising cell culture reagents and assays for culturing cells for clinical laboratory or research use

Medical clinical testing services for diagnostic or treatment purposes, namely, conducting predictive patient-specific clinical assays, modeling and assessing response of live cancer cells to investigational and approved cancer therapies; Medical services in the nature of personalized medicine services, namely, conducting predictive patient-specific clinical assays, modeling and assessing response of live cancer cells to investigational and approved cancer therapies

Medical apparatus, devices, and instruments for the analysis of tumor response to anti-cancer therapies; Kit comprising medical apparatus, devices, and instruments for performing clinical assays of anti-cancer therapies

Medical research services related to predictive tests for patient benefit from anti-cancer drugs or combination of drugs; Pharmaceutical research services, namely, preclinical assessment of pharmaceutical drugs; Scientific and technological services, namely, research in the field of anti-cancer therapies using ex vivo assays; Medical testing services, namely, performing non-clinical assays and testing for medical research purposes in the field of anti-cancer therapies, not for diagnostic or treatment purposes; Providing medical and scientific research information in the field of clinical trials, assays, and assay development, and cancer; Laboratory research in the field of oncology

Filing History

ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Feb 14, 2024 MAB3
ABANDONMENT - AFTER EX PARTE APPEAL
Feb 13, 2024 ABN3
EXPARTE APPEAL TERMINATED
Feb 13, 2024 EXPT
EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
Jan 3, 2024 EXFB
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Oct 18, 2023 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
Oct 18, 2023 GECD
ACTION CONTINUING FINAL - COMPLETED
Oct 18, 2023 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 18, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 18, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 27, 2023 ERFR
EX PARTE APPEAL-INSTITUTED
Apr 27, 2023 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Apr 27, 2023 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Apr 27, 2023 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 28, 2022 GNFN
FINAL REFUSAL E-MAILED
Oct 28, 2022 GNFR
FINAL REFUSAL WRITTEN
Oct 28, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 30, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 29, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 29, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 30, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 30, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 30, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 28, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 16, 2021 NWOS
NEW APPLICATION ENTERED
Jul 12, 2021 NWAP